The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma
暂无分享,去创建一个
C. Scrideli | L. Tone | J. A. Yunes | L. Neder | R. Oliveira | E. J. Vasconcelos | Lenisa Geron | A. Andrade | V. Suazo | C. Corrêa | A. M. Castro-Gamero | K. Borges | Simone Santos Aguiar | E. Vasconcelos
[1] M. Beckmann,et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses , 2016, Cell.
[2] Trevor J Pugh,et al. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts , 2015, Cell.
[3] M. Beckmann,et al. Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .
[4] P. Wei,et al. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs , 2015, Clinical Cancer Research.
[5] M. Levy,et al. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma , 2014, Oncogene.
[6] David T. W. Jones,et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.
[7] David T. W. Jones,et al. Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics , 2014, Neuroscience.
[8] Roland Eils,et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.
[9] C. Scrideli,et al. Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells , 2014, Anti-cancer drugs.
[10] Pei-Ming Yang,et al. Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress , 2013, Scientific Reports.
[11] M. Remke,et al. Medulloblastoma molecular dissection: the way toward targeted therapy , 2013, Current opinion in oncology.
[12] L. Ramalho,et al. Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis , 2013, Pediatric blood & cancer.
[13] S. Yip,et al. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. , 2013, Cancer research.
[14] W. Park,et al. Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes , 2013, Tumor Biology.
[15] A. Tanoue,et al. DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis , 2013, PloS one.
[16] Paul A. Northcott,et al. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies , 2013, Acta Neuropathologica.
[17] W. Zhou,et al. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. , 2013, Biochemical and biophysical research communications.
[18] Scott L. Pomeroy,et al. Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.
[19] M. Mehta,et al. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Dawson,et al. Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.
[21] W. Park,et al. Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis , 2012, Molecular Biology Reports.
[22] W. Matsui,et al. Hedgehog pathway as a drug target: Smoothened inhibitors in development , 2012, OncoTargets and therapy.
[23] Min Chen,et al. DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer , 2011, Molecular Cancer Therapeutics.
[24] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.
[25] P. Neilsen,et al. The Application of Delivery Systems for DNA Methyltransferase Inhibitors , 2011, BioDrugs.
[26] Minshan Chen,et al. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma , 2011, International journal of cancer.
[27] G. Kolios,et al. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. , 2011, World journal of gastroenterology.
[28] J. Rey,et al. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma , 2010, BMC Cancer.
[29] Michele D. Sobolewski,et al. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells , 2010, Breast Cancer Research and Treatment.
[30] J. Ravanat,et al. DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine. , 2010, Carcinogenesis.
[31] C. Rudin,et al. Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma , 2009, Science.
[32] M. Katoh,et al. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. , 2009, International journal of oncology.
[33] L. Medeiros,et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. , 2009, Cancer research.
[34] T. Deng,et al. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine. , 2009, Life sciences.
[35] C. Dullin,et al. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. , 2009, Cancer research.
[36] P. Fisher,et al. Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN) , 2008, Proceedings of the National Academy of Sciences.
[37] D. Altieri. New wirings in the survivin networks , 2008, Oncogene.
[38] A. Aboussekhra,et al. Vincristine and lomustine induce apoptosis and p21WAF1 up-regulation in medulloblastoma and normal human epithelial and fibroblast cells , 2008, Journal of Neuro-Oncology.
[39] S. Echigo,et al. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. , 2007, International journal of oncology.
[40] L. Salford,et al. Low dose Zebularine treatment enhances immunogenicity of tumor cells. , 2007, Cancer letters.
[41] T. McDonnell,et al. The sonic hedgehog signaling network in development and neoplasia. , 2007, Advances in anatomic pathology.
[42] B. Scheithauer,et al. The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.
[43] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[44] J. Fangusaro,et al. Survivin: An inhibitor of apoptosis in pediatric cancer , 2006, Pediatric blood & cancer.
[45] A. Cör,et al. Survivin is a negative prognostic marker in medulloblastoma , 2005, Neuropathology and applied neurobiology.
[46] V. Marquez,et al. Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. , 2005, Biochemical Pharmacology.
[47] Gangning Liang,et al. Preferential response of cancer cells to zebularine. , 2004, Cancer cell.
[48] Wei Ye,et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. , 2003, Journal of the National Cancer Institute.
[49] Michael D. Cole,et al. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors , 2003, Development.
[50] S. Cory,et al. The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.
[51] James M. Olson,et al. Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.
[52] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[53] P. Ingham,et al. Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.
[54] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[55] D. Rowitch,et al. Sonic hedgehog Promotes G1 Cyclin Expression and Sustained Cell Cycle Progression in Mammalian Neuronal Precursors , 2000, Molecular and Cellular Biology.
[56] David O. Morgan,et al. Principles of CDK regulation , 1995, Nature.
[57] U. Strausfeld,et al. Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.
[58] J. Uhm. Medulloblastoma Comprises Four Distinct Molecular Variants , 2011 .
[59] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[60] I. McNeish,et al. Survivin: a protein with dual roles in mitosis and apoptosis. , 2005, International review of cytology.
[61] David A Jones,et al. Activation of the p 53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2 9-deoxycytidine , 2001 .